DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Aktueller Standort:
>
> This Story


Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Operating Room Homepage

Philips teams with Medtronic on cryoablation treatment for atrial fibrillation Will form an integrated solution for cryoablation

Using comic illustrations to support patient understanding of cardiac catheterization Making patients more satisfied, less anxious and more informed

Improving surgical outcomes by imaging head and neck tumors in real time Researchers use tech developed by Perimeter Medical Imaging

Medical community finds ways to make TAVR safer for at-risk patients Improving outcomes with special procedures

Surgery gets a little more futuristic with single-incision robotic procedures UT Southwestern's Dr. Jeffrey Cadeddu discusses the da Vinci SP surgical system

The benefits of intraoperative MR Q&A with Dr. John Huston Mayo Clinic neuroradiologist discusses what the advanced capabilities mean for patients – as well as providers

What’s new in C-arms and tables? Smaller footprint and dose reduction are defining a new generation of equipment

Mentice partners with RAD-AID to bring interventional radiology training to underserved communities Providing simulator software, hardware and expertise

3D mammography helps avoid unnecessary breast biopsies, says study 33 percent difference in biopsy rate compared to standard mammography

Smith & Nephew reveal plans to build digital surgery and robotics ecosystem Developing new products, opening new facility, buying business

A Delaware judge has rejected a
motion for injunction by Hologic
to halt the sale of Minerva's
ablation solution

Court denies Hologic's attempt to halt sale of Minerva's ablation solution

by John R. Fischer , Staff Reporter
A Delaware judge has denied Hologic’s request to halt the sale of Minerva Surgical’s Endometrial Ablation solution.

The U.S. District Court for the District of Delaware rejected Hologic’s motion for an injunction against the sale last Thursday, allowing Minerva to continue selling its Endometrial Ablation System (EAS). The denial is based on another decision handed down last month by the Federal Circuit Court of Appeals, upholding a decision by the U.S. Patent and Trademark Office to invalidate a patent of Hologic’s for the detection of perforations in the uterus during ablation procedures.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“The Court of Appeals, in a unanimous decision, agreed that the patent was invalid,” Vera Elson, a lead trial lawyer and a partner for Wilson Sonsini Goodrich & Rosati, who represented Minerva Surgical, told HCB News. “We informed the court, and the court denied the motion for an injunction, which means that Minerva is free to continue selling its product. The judge concluded it was very unlikely that decision would change.”

The debate over the validity of the patent dates back to 2015 when Hologic filed a patent infringement lawsuit against Minerva, alleging that the Minerva EAS infringed upon four U.S. patents owned by Hologic via their acquisition of CYTYC, a company that had previously acquired another company called Novacept in 2004. Minerva was established in 2008 by the founder of Novacept.

Two of the four patents were dropped prior to trial, because one expired and the other was was invalidated by the U.S. Patent and Trademark Office as a result of Minerva filing for a post-grant review of the patent (PGR).

The first of the remaining two patents revolved around a method for detecting the existence of any perforations within the uterine wall lining prior to ablation. If any holes are found, then the procedure cannot move forward, as the delivery of energy from the ablation process would create heat that could seep through the hole and potentially damage nearby organs, such as the large intestine. Such damage would likely require major surgery a few days later.

Minerva filed an inter partes review (IPR) with the U.S. Patent and Trademark Office to review the validity of the patent, presenting evidence to show that similar methods had been patented before, using various techniques and challenging the assertion by Hologic that inventing such a method required a skilled artisan with experience using uterine devices.
  Pages: 1 - 2 >>

Operating Room Homepage


You Must Be Logged In To Post A Comment

Werben
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED